Effects of acetazolamide on the micro- and macro-vascular cerebral hemodynamics: A diffuse optical and transcranial doppler ultrasound study

Biomedical Optics Express

Volumn 1, Issue 5, 2010, Pages 1443-1459

  Zirak, Peyman ^a   Delgado Mederos, Raquel ^b   Martí Fàbregas, Joan ^b   Durduran, Turgut ^a  

^a ICFO INSTITUT DE CIENCIES FOTONIQUES   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; HEMOGLOBIN; NEAR INFRARED SPECTROSCOPY; ULTRASONIC APPLICATIONS;

BLOOD FLOW VELOCITY; CEREBRAL BLOOD FLOW; CEREBRAL HEMODYNAMICS; DIFFUSE CORRELATION SPECTROSCOPY; DIFFUSE OPTICAL; METABOLIC RATES; MIDDLE CEREBRAL ARTERY; REAL TIME; TRANSCRANIAL DOPPLER; TRANSCRANIAL DOPPLER ULTRASOUND; VASCULATURE;

HEMODYNAMICS;

EID: 79955448160     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.1.001443     Document Type: Article

References (75)

1. N. Lassen, "Cerebral blood flow and oxygen consumption in man, " Physiol. Rev. 39(2), 183-238 (1959).
2. M. Fog, "Cerebral circulation: The reaction of the pial arteries to a fall in blood pressure, " Arch. Neurol. Psychiatry 37, 351 (1937).
3. G. I. Mchedlishvili, N. P. Mitgvaria, and L. G. Ormotsadze, "Vascular mechanisms controlling a constant blood supply to the brain ("autoregulation"), " Stroke 4(5), 742-750 (1973).
4. B. Widder, B. Kleiser, and H. Krapf, "Course of cerebrovascular reactivity in patients with carotid artery occlusions, " Stroke 25(10), 1963-1967 (1994).
5. S. Vorstrup, L. Henriksen, and O. Paulson, "Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen, " J. Clin. Invest. 74(5), 1634-1639 (1984).
6. H. W. Schytz, T. Wienecke, L. T. Jensen, J. Selb, D. A. Boas, and M. Ashina, "Changes in cerebral blood flow after acetazolamide: an experimental study comparing near-infrared spectroscopy and SPECT, " Eur. J. Neurol. 16(4), 461-467 (2009).
7. G. Settakis, C. Molńar, L. Kerényi, J. Kolĺar, D. Legemate, L. Csiba, and B. F̈ulesdi, "Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature, " Eur. J. Neurol. 10(6), 609-620 (2003).
8. A. Piepgras, P. Schmiedek, G. Leinsinger, R. Haberl, C. Kirsch, and K. Einhaupl, "A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide, " Stroke 21(9), 1306-1311 (1990).
9. M. I. Chimowitz, A. J. Furlan, S. C. Jones, C. A. Sila, R. L. Lorig, L. Paranandi, and G. J. Beck, "Transcranial Doppler assessment of cerebral perfusion reserve in patients with carotid occlusive disease and no evidence of cerebral infarction, " Neurology 43(2), 353-357 (1993).
10. W. Sorteberg, K. F. Lindegaard, K. Rootwelt, A. Dahl, R. Nyberg-Hansen, D. Russell, and H. Nornes, "Effect of acetazolamide on cerebral artery blood velocity and regional cerebral blood flow in normal subjects, " Acta Neurochir. (Wien) 97(3-4), 139-145 (1989).
11. P. Demolis, G. Florence, L. Thomas, Y. R. Tran Dinh, J. F. Giudicelli, J. Seylaz, and N. J. Alkayed, "Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? an experimental study, " Stroke 31(2), 508-515 (2000).
12. U. Sabatini, P. Celsis, G. Viallard, A. Rascol, and J. P. Marc-Vergnes, "Quantitative assessment of cerebral blood volume by single-photon emission computed tomography, " Stroke 22(3), 324-330 (1991).
13. H. Yamaguchi, H. Yamauchi, S. Hazama, H. Hamamoto, and N. Inoue, "Correlation between cerebral oxygen metabolism and cerebral blood flow simultaneously measured before and after acetazolamide administration, " J. Biomed. Opt. 4(4), 418 (1999).
14. Y. F. Yen, A. S. Field, E. M. Martin, N. Ari, J. H. Burdette, D. M. Moody, and A. M. Takahashi, "Test-retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge, " Magn. Reson. Med. 47(5), 921-928 (2002).
15. J. Detre, O. Samuels, D. Alsop, J. Gonzalez-At, S. Kasner, and E. Raps, "Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis, " J. Magn. Reson. Imaging 10(5), 870-875 (1999).
16. B. Weber, G. Westera, V. Treyer, C. Burger, N. Khan, and A. Buck, "Constant-Infusion H215O PET and Acetazolamide Challenge in the Assessment of Cerebral Perfusion Status, " J. Nucl. Med. 45(8), 1344-1350 (2004).
17. M. Matteis, E. Troisi, B. Monaldo, C. Caltagirone, and M. Silvestrini, "Age and sex differences in cerebral hemodynamics: a transcranial Doppler study, " Stroke 29(5), 963-967 (1998).
18. B. Eicke, E. Buss, R. B̈ahr, G. Hajak, and W. Paulus, "Influence of acetazolamide and CO2 on extracranial flow volume and intracranial blood flow velocity, " Stroke 30(1), 76-80 (1999).
19. B. F̈ulesdi, M. Limburg, L. Oĺah, D. Bereczki, L. Csiba, and J. Kollar, "Lack of gender difference in acetazolamide-induced cerebral vasomotor reactivity in patients suffering from type-1 diabetes mellitus, " Acta Diabetol. 38(3), 107-112 (2001).
20. A. Villringer and B. Chance, "Non-invasive optical spectroscopy and imaging of human brain function, " Trends Neurosci. 20(10), 435-442 (1997).
21. E. Hillman, "Optical brain imaging in vivo: techniques and applications from animal to man, " J. Biomed. Opt. 12, 051402 (2007).
22. T. Durduran, R. Choe, W. Baker, and A. G. Yodh, "Diffuse optics for tissue monitoring and tomography, " Rep. Prog. Phys. 73(7), 076701 (2010).
23. E. Keller, M. Wolf, M. Martin, and Y. Yonekawa, "Estimation of cerebral oxygenation and hemodynamics in cerebral vasospasm using indocyaningreen dye dilution and near infrared spectroscopy: a case report, " J. Neurosurg. Anesthesiol. 13(1), 43-48 (2001).
24. B. Wagner, S. Gertsch, R. Ammann, and J. Pfenninger, "Reproducibility of the blood flow index as noninvasive, bedside estimation of cerebral blood flow, " Intensive Care Med. 29(2), 196-200 (2003).
25. D. Boas, G. Strangman, J. Culver, R. Hoge, G. Jasdzewski, R. Poldrack, B. Rosen, and J. Mandeville, "Can the cerebral metabolic rate of oxygen be estimated with near-infrared spectroscopy?" Phys. Med. Biol. 48(15), 2405-2418 (2003).
26. I. Tachtsidis, T. Leung, D. Delpy, C. Elwell, M. Tisdall, and M. Smith, "Cerebral blood flow assessment with indocyanine green bolus transit detection by near-infrared spectroscopy before and after acetazolamide challenge in humans, " Biomedical Optics (2006).
27. M. Kaminogo, A. Ichikura, S. Shibata, T. Toba, and M. Yonekura, "Effect of acetazolamide on regional cerebral oxygen saturation and regional cerebral blood flow, " Stroke 26(12), 2358-2360 (1995).
28. M. Holzschuh, C. Woertgen, C. Metz, and A. Brawanski, "Comparison of changes in cerebral blood flow and cerebral oxygen saturation measured by near infrared spectroscopy (NIRS) after acetazolamide, " Acta Neurochir. (Wien) 139(1), 58-62 (1997).
29. D. Boas, L. Campbell, and A. Yodh, "Scattering and imaging with diffusing temporal field correlations, " Phys. Rev. Lett. 75(9), 1855-1858 (1995).
30. D. Boas and A. Yodh, "Spatially varying dynamical properties of turbid media probed with diffusing temporal light correlation, " J. Opt. Soc. Am. A 14(1), 192-215 (1997).
31. E. M. Buckley, N. M. Cook, T. Durduran, M. N. Kim, C. Zhou, R. Choe, G. Yu, S. Schultz, C. M. Sehgal, D. J. Licht, P. H. Arger, M. E. Putt, H. H Hurt, and A. G. Yodh, "Cerebral hemodynamics in preterm infants during positional intervention measured with diffuse correlation spectroscopy and transcranial Doppler ultrasound, " Opt. Express 17(15), 12571-12581 (2009).
32. N. Roche-Labarbe, F. Wallois, E. Ponchel, G. Kongolo, and R. Grebe, "Coupled oxygenation oscillation measured by NIRS and intermittent cerebral activation on EEG in premature infants, " Neuroimage 36(3), 718-727 (2007).
33. T. Durduran, G. Yu, M. Burnett, J. Detre, J. Greenberg, J. Wang, C. Zhou, and A. Yodh, "Diffuse optical measurement of blood flow, blood oxygenation, and metabolism in a human brain during sensorimotor cortex activation, " Opt. Lett. 29(15), 1766-1768 (2004).
34. J. Li, G. Dietsche, D. Iftime, S. Skipetrov, G. Maret, T. Elbert, B. Rockstroh, and T. Gisler, "Noninvasive detection of functional brain activity with near-infrared diffusing-wave spectroscopy, " J. Biomed. Opt. 10(4), 044002 (2005).
35. T. Durduran, C. Zhou, E. M. Buckley, M. Kim, G. Yu, R. Choe, J. Gaynor, T. Spray, S. Durning, S. Mason, L. Montenegro, S. Nicolson, R. A. Zimmerman, M. Putt, J. Wang, J. H. Greenberg, J. A. Detre, A. Yodh, and D. Licht, "Optical measurement of cerebral hemodynamics and oxygen metabolism in neonates with congenital heart defects, " J. Biomed. Opt. 15(3), 037004 (2010).
36. M. Kim, T. Durduran, S. Frangos, B. Edlow, E. Buckley, H. Moss, C. Zhou, G. Yu, R. Choe, M. Wilensky, R. Wolf, M. Grady, J. Greenberg, J. Levine, A. Yodh, J. Detre, and W. Kofke, "Noninvasive measurement of cerebral blood flow and blood oxygenation using near-infrared and diffuse correlation spectroscopies in critically brain-injured adults, " Neurocrit. Care 12(2), 173-180 (2010).
37. T. Durduran, C. Zhou, B. Edlow, G. Yu, R. Choe, M. Kim, B. Cucchiara, M. Putt, Q. Shah, S. Kasner, J. Greenberg, A. Yodh, and J. Detre, "Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients, " Opt. Express 17(5), 3884-3902 (2009).
38. A. Carney and E. Anderson, "The system approach to brain blood flow, " Adv. Neurol. 30, 1-30 (1981).
39. R. Roski, R. Spetzler, M. Owen, K. Chandar, J. Sholl, and F. Nulsen, "Reversal of seven-year old visual field defect with extracranial-intracranial arterial anastomosis. " Surg. Neurol. 10(4), 267-268 (1978).
40. P. Frykholm, J. L. R. Andersson, J. Valtysson, H. C. Silander, L. Hillered, L. Persson, Y. Olsson, W. R. Yu, G. Westerberg, Y. Watanabe, B. Langstr̈om, and P. Enblad, "A metabolic threshold of irreversible ischemia demonstrated by PET in a middle cerebral artery occlusion-reperfusion primate model, " Acta Neurol. Scand. 102(1), 18-26 (2000).
41. J. Posner and F. Plum, "The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy, " J. Clin. Invest. 39(8), 1246-1258 (1960).
42. B. Laux and M. Raichle, "The effect of acetazolamide on cerebral blood flow and oxygen utilization in the rhesus monkey, " J. Clin. Invest. 62(3), 585-592 (1978).
43. B. Kleiser and B. Widder, "Course of carotid artery occlusions with impaired cerebrovascular reactivity, " Stroke 23(2), 171-174 (1992).
44. W. Powers, L. Tempel, and R. Grubb, Jr, "Influence of cerebral hemodynamics on stroke risk: one-year follow-up of 30 medically treated patients, " Ann. Neurol. 25(4), 325-330 (1989).
45. D. Ehrenreich, R. Burns, R. Alman, and J. Fazekas, "Influence of acetazolamide on cerebral blood flow, " Arch. Neurol. 5, 227-232 (1961).
46. J. Culver, T. Durduran, D. Furuya, C. Cheung, J. Greenberg, and A. Yodh, "Diffuse optical tomography of cerebral blood flow, oxygenation, and metabolism in rat during focal ischemia, " J. Cereb. Blood Flow Metab. 23(8), 911-924 (2003).
47. V. Toronov, E. D'Amico, D. Hueber, E. Gratton, B. Barbieri, and A. Webb, "Optimization of the signal-to-noise ratio of frequency-domain instrumentation for near-infrared spectro-imaging of the human brain, " Opt. Express 11(21), 2717-2729 (2003).
48. S. Arridge, M. Cope, and D. Delpy, "The theoretical basis for the determination of optical pathlengths in tissue: temporal and frequency analysis, " Phys. Med. Biol. 37(7), 1531-1560 (1992).
49. P. Van der Zee, M. Cope, S. Arridge, M. Essenpreis, L. Potter, A. Edwards, J. Wyatt, D. McCormick, S. Roth, E. Reynolds, and D. T. Delpy, "Experimentally measured optical pathlengths for the adult head, calf and forearm and the head of the newborn infant as a function of inter optode spacing, " Adv. Exp. Med. Biol. 316, 143-153 (1993).
50. G. Strangman, M. Franceschini, and D. Boas, "Factors affecting the accuracy of near-infrared spectroscopy concentration calculations for focal changes in oxygenation parameters, " Neuroimage 18(4), 865-879 (2003).
51. A. Duncan, J. Meek, M. Clemence, C. Elwell, L. Tyszczuk, M. Cope, and D. Delpy, "Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy, " Phys. Med. Biol. 40(2), 295-304 (1995).
52. S. Kohri, Y. Hoshi, M. Tamura, C. Kato, Y. Kuge, and N. Tamaki, "Quantitative evaluation of the relative contribution ratio of cerebral tissue to near-infrared signals in the adult human head: a preliminary study, " Physiol. Meas. 23(2), 301-312 (2002).
53. J. Mayhew, D. Johnston, J. Martindale, M. Jones, J. Berwick, and Y. Zheng, "Increased oxygen consumption following activation of brain: theoretical footnotes using spectroscopic data from barrel cortex, " Neuroimage 13(6), 975-987 (2001).
54. A. Torricelli, A. Pifferi, P. Taroni, E. Giambattistelli, and R. Cubeddu, "In vivo optical characterization of human tissues from 610 to 1010 nm by time-resolved reflectance spectroscopy, " Phys. Med. Biol. 46(8), 2227-2237 (2001).
55. K. Hornik, "The R FAQ, " (2010). ISBN 3-900051-08-9.
56. R. Grubb, M. Raichle, J. Eichling, and M. Ter-pogossian, "The effects of changes in PaCO2 cerebral blood volume, blood flow, and vascular mean transit time, " Stroke 5(5), 630-639 (1974).
57. T. Leung, I. Tachtsidis, M. Tisdall, C. Pritchard, M. Smith, and C. Elwell, "Estimating a modified Grubb's exponent in healthy human brains with near infrared spectroscopy and transcranial Doppler, " Physiol. Meas. 30(1), 1-12 (2009).
58. P. Ulrich, T. Becker, and O. Kempski, "Correlation of cerebral blood flow and MCA flow velocity measured in healthy volunteers during acetazolamide and CO2 stimulation* 1, " J. Neurol. Sci. 129(2), 120-130 (1995).
59. A. Dahl, K. Lindegaard, D. Russell, R. Nyberg-Hansen, K. Rootwelt, W. Sorteberg, and H. Nornes, "A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity, " Stroke 23(1), 15-19 (1992).
60. T. Kreisig, P. Schmiedek, G. Leinsinger, K. Einḧaupl, and E. Moser, "133Xe-DSPECT: normal values of resting cerebral blood flow and reserve capacity, " Nucl. Med. (Stuttg.) 26(5), 192-197 (1987).
61. A. Dahl, D. Russell, R. Nyberg-Hansen, K. Rootwelt, and P. Mowinckel, "Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects. " J. Cereb. Blood Flow Metab. 14(6), 974-981 (1994).
62. I. Tachtsidis, M. Tisdall, D. Delpy, M. Smith, and C. Elwell, "Measurement of cerebral tissue oxygenation in young healthy volunteers during acetazolamide provocation: a transcranial Doppler and near-infrared spectroscopy investigation, " Adv. Exp. Med. Biol. 614, 389-396 (2008).
63. E. M. Buckley, N. M. Cook, T. Durduran, M. N. Kim, C. Zhou, R. Choe, G. Yu, S. Schultz, C. M. Sehgal, D. J. Licht, P. H. Arger, M. E. Putt, H. H. Hurt, and A. G. Yodh, "Cerebral hemodynamics in preterm infants during positional intervention measured with diffuse correlation spectroscopy and transcranial Doppler ultrasound, " Opt. Express 17(15), 12571-12581 (2009).
64. N. Roche-Labarbe, S. Carp, A. Surova, M. Patel, D. Boas, P. Grant, and M. Franceschini, "Noninvasive optical measures of CBV, StO2, CBF index, and rCMRO2 in human premature neonates' brains in the first six weeks of life, " Hum. Brain Mapp. 31(3), 341-352 (2010).
65. W. Sorteberg, K. Lindegaard, K. Rootwelt, A. Dahl, D. Russell, R. Nyberg-Hansen, and H. Nornes, "Blood velocity and regional blood flow in defined cerebral artery systems, " Acta Neurochir. (Wien) 97(1-2), 47-52 (1989).
66. H. Kontos, "Validity of cerebral arterial blood flow calculations from velocity measurements, " Stroke 20(1), 1-3 (1989).
67. T. Davis, K. Kwong, R. Weisskoff, and B. Rosen, "Calibrated functional MRI: mapping the dynamics of oxidative metabolism, " Proc. Natl. Acad. Sci. U.S.A. 95(4), 1834-1839 (1998).
68. R. Hoge, J. Atkinson, B. Gill, G. Crelier, S. Marrett, and G. Pike, "Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex, " Proc. Natl. Acad. Sci. U.S.A. 96(16), 9403-9408 (1999).
69. S. Kim, E. Rostrup, H. Larsson, S. Ogawa, and O. Paulson, "Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation, " Magn. Reson. Med. 41(6), 1152-1161 (1999).
70. S. Carp, G. Dai, D. Boas, M. Franceschini, and Y. Kim, "Validation of diffuse correlation spectroscopy measurements of rodent cerebral blood flow with simultaneous arterial spin labeling mri; towards mri-optical continuous cerebral metabolic monitoring, " Biomed. Opt. Express 1(2), 553-565 (2010).
71. L. Gagnon, M. Desjardins, J. Jehanne-Lacasse, L. Bherer, and F. Lesage, "Investigation of diffuse correlation spectroscopy in multi-layered media including the human head, " Opt. Express 16(20), 15514-15530 (2008).
72. M. Kim, T. Durduran, S. Frangos, B. Edlow, E. Buckley, H. Moss, C. Zhou, G. Yu, R. Choe, E. Maloney-Wilensky, R. L. Wolf, M. S. Grady, J. H. Greenberg, J. M. Levine, A. G. Yodh, J. A. Detre, and W. A. Kofke, "Noninvasive measurement of cerebral blood flow and blood oxygenation using near-infrared and diffuse correlation spectroscopies in critically brain-injured adults, " Neurocrit. Care 12(2), 173-180 (2010).
73. M. Dyken, E. Klatte, O. Kolar, and C. Spurgeon, "Complete occlusion of common or internal carotid arteries: clinical significance, " Arch. Neurol. 30(5), 343-346 (1974).
74. R. Cote, H. Barnett, and D. Taylor, "Internal carotid occlusion: a prospective study, " Stroke 14(6), 898-902 (1983).
75. S. Durham, H. Smith, M. Rutigliano, and H. Yonas, "Assessment of cerebral vasoreactivity and stroke risk using Xe-CT acetazolamide challenge, " Stroke 22, 138 (1991).